Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.83
Delayed Data
As of 4:00pm ET
 +0.22 / +2.56%
Today’s Change
5.21
Today|||52-Week Range
16.30
-12.23%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close8.61
Today’s open8.60
Day’s range8.43 - 8.84
Volume346,711
Average volume (3 months)1,058,935
Market cap$343.1M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-73.20%
Earnings growth (this year)-8.04%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
CRVSCorvus Pharmaceutica...+0.24+1.47%
CRBPCorbus Pharmaceutica...+0.10+1.29%
ADMSAdamas Pharmaceutica...+0.40+2.58%
ARNAArena Pharmaceutical...-0.03-2.14%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$47.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts


Search for Jobs